Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies Licenses Genetics Research's CRISPR DNA Enrichment Technology

NEW YORK – DNA technology startup Genetics Research said on Tuesday that Oxford Nanopore Technologies has licensed its intellectual property relating to CRISPR-based DNA target enrichment.

Under the non-exclusive agreement, Oxford Nanopore can include the technology, which targets long DNA fragments with specific sequences, in its DNA and RNA nanopore sequencing products.

Financial and other terms of the deal were not disclosed.

Genetics Research, based in Wakefield, Massachusetts, has developed a low-cost sequence-specific technology platform, called Negative Enrichment, that uses CRISPR/Cas9 to enrich DNA fragments from a complex background.

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.